🔮 OOTWOracle · All predictions · Odds sheet · Track record · How it works · Benchmark
Answers: Will psilocybin be FDA-approved? · Will MDMA be approved? · When will psychedelics be legal?

CMPS stays below $16 through October absent a Phase 3 durability readout; no M&A bid emerges this quarter.

Predicted 2026-09-01 · Resolves 2026-10-31 · market · USA
62%
ORACLE CONFIDENCE
⏳ Pending
Every outcome is scored publicly in the ledger.

COMPASS Pathways stock (trading on the Nasdaq stock exchange under the symbol CMPS) will close every single trading day at or below $16 between now and October 31, 2026, and no bigger company will swoop in with a buyout offer during that stretch. Without a clear date for when key trial results will be announced, big institutional investors — the pension funds and asset managers that move markets — have little reason to pile in.

Resolution rule: YES if CMPS (NASDAQ:CMPS) closes at or below $16.00 on every trading day from 2026-09-01 through 2026-10-31 AND no acquisition/tender offer for COMPASS Pathways is publicly announced in that window. Checked via Nasdaq/Yahoo Finance closing prices and COMPASS IR/SEC 8-K filings on 2026-10-31.

At $13.23 and down today, COMPASS lacks a near-term catalyst. Institutions want de-risked filing-stage assets. Until a readout date is set, it drifts.

5 new falsifiable predictions, every day at 12:05 PM ET.
Get tomorrow's Oracle →
Marketing byAN
Sacred 5-MeO-DMT Ceremonies · Miami
The Oldest Prayer, Remembered

Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.

Join the Free Weekly Circle →